Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Desmosine
67%
Elastin
41%
Acute Myocardial Infarction
38%
Patients with Heart Failure
30%
Elastin Degradation
29%
Heart Failure
28%
Metformin
27%
Insulin Resistance
24%
All-cause Mortality
21%
Marfan Syndrome
20%
Ruptured Abdominal Aortic Aneurysm (rAAA)
20%
Outcome Prediction
19%
Chronic Heart Failure
19%
Patients with Coronary Artery Disease
19%
Right Ventricular Pacing
19%
Placebo
18%
Tayside
17%
Bicuspid Aortic Valve
17%
Angiotensin-converting Enzyme Inhibitor (ACEi)
16%
Endothelial Function
16%
Scotland
15%
Type 2 Diabetes Mellitus (T2DM)
15%
Aneurysm Size
15%
Degradation Products
14%
Myocardial Infarction
14%
Aortopathy
14%
Aortic Root
14%
Type 2 Diabetic Patients
13%
Left Ventricular Dysfunction
13%
Root Length
13%
Atrial Fibrillation
12%
Left Ventricular Hypertrophy
12%
Without Diabetes
12%
Event-independent
12%
Amiodarone Therapy
12%
Pulmonary Hypertension
12%
Prazosin
12%
Cardiac Output
12%
Atrial Natriuretic Peptide
11%
Left Ventricular Systolic Dysfunction
11%
Brain Natriuretic Peptide
11%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
Natriuretic Peptides
11%
Cardiovascular Disease
10%
Hospitalization
10%
Heart Failure Patients
10%
Arrhythmia
10%
Non-diabetic
10%
Pre-diabetes (pre-DM)
10%
Renin-angiotensin System
9%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Brain Natriuretic Peptide
32%
Renin
30%
Placebo
30%
Angiotensin
28%
All Cause Mortality
21%
Loop Diuretic Agent
19%
Sodium
19%
Atrial Fibrillation
19%
Acute Heart Infarction
19%
Atrial Natriuretic Factor
19%
Diabetes Mellitus
18%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Heart Ventricle Remodeling
15%
Statin (Protein)
14%
Adverse Drug Reaction
13%
Natriuretic Factor
13%
Amiodarone
13%
Maturity Onset Diabetes of the Young
13%
Cohort Study
12%
Syndrome X
12%
Prazosin
12%
Dapagliflozin
12%
QT Prolongation
12%
Long QT Syndrome
12%
Diseases
11%
Insulin Resistance
10%
Heart Left Ventricle Hypertrophy
9%
Insulin
9%
Normal Human
9%
Atherosclerosis
9%
Carvedilol
9%
Endothelial Dysfunction
8%
Prevalence
8%
Angiotensin Receptor Antagonist
8%
Heart Left Ventricle Failure
8%
Pathophysiology
8%
Hypertension
7%
Biological Marker
7%
Aortic Stenosis
7%
Glucose
7%
Antiarrhythmic Agent
7%
Heart Arrhythmia
7%
Nitric Acid Derivative
7%
Randomized Controlled Trial
7%
Metformin
7%
Allopurinol
7%
Pharmacotherapy
6%
Aldosterone
6%
Noradrenalin
6%
Medicine and Dentistry
Desmosine
32%
Biological Marker
30%
Congestive Heart Failure
27%
Glycon
26%
Insulin Resistance
23%
Coronary Artery Disease
22%
Elastin
22%
Cardiovascular System
21%
Left Ventricular Hypertrophy
20%
Diabetes
15%
Maturity Onset Diabetes of the Young
15%
Cardiovascular Disease
14%
Aortic Stenosis
14%
Aortopathy
13%
Brain Natriuretic Peptide
12%
Acute Heart Infarction
12%
Vasomotor
12%
Myocardial Infarction
12%
Bicuspid Aortic Valve
12%
ACE Inhibitor
11%
Placebo
11%
Atrial Natriuretic Factor
10%
Endothelial Function
10%
Renin Angiotensin Aldosterone System
9%
Endothelial Dysfunction
9%
Prevalence
8%
Echocardiography
8%
Cardiac Magnetic Resonance Imaging
8%
Liquid Chromatography-Mass Spectrometry
8%
Patient with Type 2 Diabetes
7%
Aortic Root
7%
Aortic Dissection
7%
Adipose Tissue
7%
Cross Sectional Study
7%
Pathophysiology
7%
Blood Pressure
7%
Coronary Flow Reserve
7%
Adverse Outcome
7%
Troponin I
7%
Marfan Syndrome
6%
Resistance Index
6%
Atrial Fibrillation
6%
Beta Adrenergic Receptor Blocking Agent
6%
Randomized Controlled Trial
6%
Left Ventricular Systolic Dysfunction
6%
Long QT Syndrome
6%
Valvular Heart Disease
6%
Endothelial Nitric Oxide Synthase
6%
Dapsone
6%
Dipyridamole
6%
